Israeli startup CytoReason, maker of a computation model to map and compare treatments, announced it secured $80 million in funding. Pfizer, OurCrowd, NVIDIA and Thermo Fisher Scientific participated in the round.
WHAT IT DOES
CytoReason offers life…
Concerns about AI should not stop progress. They should prompt us to think about how to apply such powerful processing, argue Rebecca Hughes and Paul Davies
In the next 10 to 15 years, AI technology…
What You Should Know:
– Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP…
Continue Reading
Replacing registered nurses with non-RN staff is dangerous to patients, according to a new study from the Center for Health Outcomes and Policy Research at the University of Pennsylvania School of Nursing published in Medical…
Continue Reading
The discovery of patterns associated with diagnosis, prognosis, and therapy response in digital pathology images often requires intractable labeling of large quantities of histological objects. Here we release an open-source labeling tool, PatchSorter, which…
Continue Reading
Introduction
In the realm of cancer detection, artificial intelligence (AI) has shown immense promise. However, the development of effective AI algorithms depends heavily on the availability of high-quality, annotated medical data. A groundbreaking method developed…
Google Research and Google DeepMind recently released a paper announcing the creation of a new LLM for drug discovery and therapeutic development dubbed Tx-LLM, fine-tuned from PaLM-2.Tx-LLM utilizes the tech giant’s PaLM-2, its generative…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.
– These comprehensive datasets, built through collaborations with various health…
Continue Reading
California-based Allez Health, formerly Zense-Life Inc., announced it secured $60 million in Series A+ financing. The round was led by strategic investor Osang Healthcare Co., Ltd., with participation from existing investors.
WHAT IT DOES
Allez Health is…
What You Should Know:
– Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence…
Continue Reading
